Avidity Partners Management LP Portfolio Holdings

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Avidity Partners Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.63 Billion distributed in 81 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $80.6M, Intuitive Surgical Inc with a value of $72.8M, Natera, Inc. with a value of $70.7M, Acadia Healthcare Company, Inc. with a value of $62.5M, and Neurocrine Biosciences Inc with a value of $53M.

Examining the 13F form we can see an decrease of $404M in the current position value, from $2.03B to 1.63B.

Avidity Partners Management LP is based out at Dallas, TX

Below you can find more details about Avidity Partners Management LP portfolio as well as his latest detailed transactions.

Portfolio value $1.63 Billion
Healthcare: $1.6 Billion
Basic Materials: $31.9 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.11B
$7.3 Million 0.45% of portfolio
169,000
Q3 2024 Reduced 68.17%
$572M
$7.11 Million 0.44% of portfolio
425,000
Q3 2024 Reduced 72.75%
$1.44B
$6.23 Million 0.38% of portfolio
200,000
Q2 2024 Reduced 30.17%
$1.52B
$5.93 Million 0.36% of portfolio
165,000
Q3 2024 New
$121B
$5.77 Million 0.35% of portfolio
100,000
Q3 2024 Reduced 68.25%
$164M
$5 Million 0.31% of portfolio
1,465,000
Q3 2024 Added 79.53%
$2.5B
$4.33 Million 0.27% of portfolio
27,600
Q3 2024 New
$511M
$3.87 Million 0.24% of portfolio
5,026,000
Q1 2024 Added 0.01%
$280M
$3.32 Million 0.2% of portfolio
673,618
Q3 2024 New
$3.55B
$2.72 Million 0.17% of portfolio
99,000
Q3 2024 Reduced 89.1%
$306M
$2.69 Million 0.16% of portfolio
694,000
Q2 2024 Reduced 65.13%
$40.5M
$2.16 Million 0.13% of portfolio
1,448,728
Q4 2023 Added 9.8%
$34.9M
$1.84 Million 0.11% of portfolio
890,000
Q3 2024 New
$67M
$1.68 Million 0.1% of portfolio
2,018,500
Q2 2024 Reduced 75.68%
$56.1M
$1.28 Million 0.08% of portfolio
1,188,178
Q2 2023 Reduced 20.99%
$27.8M
$848,000 0.05% of portfolio
1,631,143
Q3 2024 New
Alto Neuroscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 68.38%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 7.35%
Cybin Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Oruka Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 3.33%
Neurogene Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 41.58%
-
$0 0.0% of portfolio
-
Q3 2024 Added 59.07%
Syros Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 36.48%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 59.92%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 13.38%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 27.76%
Caremax Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Instil Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 81
  • Current Value $1.63 Billion
  • Prior Value $2.03 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 20 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 37 stocks
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email